What does Keros Therapeutics, Inc. (KROS) do?

Keros Therapeutics, Inc. (KROS) is a publicly traded company in the Healthcare sector.

What sector does KROS operate in?

Keros Therapeutics, Inc. operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find KROS earnings analysis?

AlphaOS publishes an earnings intelligence page for Keros Therapeutics, Inc. (KROS) covering results, guidance context, and AI-assisted analysis. See /stocks/KROS/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

KROS

Keros Therapeutics, Inc.

Healthcare · Pharmaceutical Preparations

$11.19Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Keros Therapeutics, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -100% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -100% YoY in Q2 FY2026

Pipeline evidence · 0d ago

KROS's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on KROS.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full KROS earnings analysis

Reported figures for Keros Therapeutics, Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for Keros Therapeutics, Inc. (KROS) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 29, 2026 at $11.19.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Keros Therapeutics, Inc. (KROS)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Keros Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Market cap:: $221.87M
Revenue:: $367,000

KROS earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Keros Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.